Home
About us
What we do
How we work
Our strategy
History
Management
Discovery
Overview
Drug discovery
Discovery platform
Other programmes
Development
Overview
Cancer – Chk1 kinase
Autoimmune - TYK2/JAK1 kinases
Cancer - TYK2/JAK1 kinases
Cancer – Aurora+FLT3 kinase
Partners
Overview
Current collaborations
Investors
Document centre
Corporate governance
Share price and RNS
AIM rule 26
Advisers
News
Press releases
News archive
Events
Patents and publications
Presentations and press
Contact
Press releases
News archive
Events
Patents and publications
Presentations and press
Presentations and press
Video presentations and interviews
"Sareum Holdings plc heartened by Sierra Oncology Progress" Proactive Investors, March 2018
Biotech Capital Conference, February 2017
PharmaTV, November 2016
Audio presentations
Cancer drug payment nudges Sareum Holdings into maiden profit - Proactive Investors, February 2017
Licensing deal "a validation of Sareum's business model" - Proactive Investors, November 2016
How did Sareum Holdings perform in its final results? - Share Radio, November 2016
Sareum 'very excited' by TYK2 inhibitor results says chief scientific officer - Proactive Investors, October 2016
CEO Dr Tim Mitchell talks about Sareum - Share Radio, October 2016
Chk1 Licence Deal - ProNAi Webcast, September 2016
Chk1 Licence Deal - Proactive Investors, September 2016
Slide presentations
Biotech Capital Conference, February 2017
Proactive Investors One2One Investor Forum, May 2016
In the news
Cambridge News "Sareum turns a profit after spectacular six months"
Link to online article
20 February 2017
Business Weekly "Sareum posts maiden profit"
Link to online article
20 February 2017
Cambridge News "Why Sareum is in the money again"
Link to online article
11 January 2017
Cambridge Business "Little Big Firm"
Link to online article
p85-87, December 2016
Download Article PDF
Cambridge News "CEO 'delighted' with progress at cancer drug firm Sareum"
Link to online article
2 November 2016
Business Weekly "Japan and Singapore patents for Sareum Technology"
Link to online article
20 October 2016
Cambridge News "Celebrate Cambridge: high time for life sciences"
Link to online article
28 September 2016
City AM "Cambridge biotech firm sees shares jump over 100 per cent on US pharma deal"
Link to online article
27 September 2016
Cambridge News "Share price leaps 150% for Cambridge cancer company"
Link to online article
27 September 2016
Genetic Engineering & Biotechnology News "ProNAi Licenses Checkpoint Kinase 1 Inhibitor..."
Link to online article
27 September 2016
Business Weekly "US deal hands Sareum share of potential $328M windfall"
Link to online article
27 September 2016
Business Weekly "China and Hong Kong patent boost for Sareum"
Link to online article
8 August 2016
Cambridge News "Movers and shakers: new chairman for Sareum..."
Link to online article
24 May 2016
Cambridge News "Cambridge cancer drug company sees share price zoom"
Link to online article
5 April 2016
Cambridge News "Sareum helps develop 'chemotherapy-booster' for patients with lung and pancreatic cancer"
Link to online article
27 July 2015
Cambridge News "Sareum lands £140K to develop molecule that could treat leukaemia".
Link to online article
23 June 2015
Cambridge News, "Sareum Signs China Deal".
Link to online article
3 December 2013
Cambridge News, "High Hopes for New Sareum Cancer Drug".
Link to online article
16 August 2011
Cambridge News, "Star Status for Sareum".
Link to online article
6 July 2011
Interactive Investor, "AIM Winners and Losers (01/01 - 30/06/11)".
Link to online article
5 July 2011
Cambridge News, "Tenfold Growth in Two Months".
Download PDF
or
Link to online article
24 May 2011
@Sareumplc Latest tweet
RT
@sierraoncology
: Sierra sponsors the DNA Damage Response Therapeutics Summit next week in Boston. On Jan 30, CSO Dr. Chris Hassig will p…
via @Sareumplc
View more